Clinical trials
Recruiting Colorectal Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
252 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 11 |
| 2022 | 16 |
| 2023 | 37 |
| 2024 | 67 |
| 2025 | 63 |
| 2026 | 48 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 252 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 23 |
| Sun Yat-sen University | 17 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 8 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 |
| West China Hospital | 6 |
| Zhejiang University | 6 |
| The First Affiliated Hospital of Nanchang University | 5 |
| Shanghai Changzheng Hospital | 4 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 252 |
| Stomach Neoplasms | 25 |
| Carcinoma, Non-Small-Cell Lung | 21 |
| Pancreatic Neoplasms | 21 |
| Breast Neoplasms | 16 |
| Esophageal Neoplasms | 11 |
| Lung Neoplasms | 11 |
| Ovarian Neoplasms | 11 |
| Carcinoma, Hepatocellular | 10 |
| Neoplasm Metastasis | 10 |
Trials
Showing 1 to 25 of 252. Each trial links to its page on Pharma Observatory.
152 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.